{"id":6534,"date":"2021-02-09T12:02:04","date_gmt":"2021-02-09T11:02:04","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2021\/02\/Seventure-round-up_IO-release-final.pdf"},"modified":"2021-02-09T12:02:04","modified_gmt":"2021-02-09T11:02:04","slug":"seventure-round-up_io-release-final","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/health-for-life-capital-ii-fund-managed-by-seventure-partners-makes-two-new-immuno-oncology-i-o-investments\/seventure-round-up_io-release-final\/","title":{"rendered":"Seventure round-up_IO release final"},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-6534","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n